Medicine and Dentistry
AS04
100%
Cervical Cancer
20%
Cervical Cancer Prevention
20%
Cervical Cancer Screening
20%
Cost-Effectiveness Analysis
100%
Head
20%
Health Care Cost
80%
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 6
40%
Lifespan
20%
Mass Immunization
20%
Papillomavirus Infection
20%
Quality Adjusted Life Year
40%
Screening
60%
Vaccine
20%
Wart Virus
100%
Nursing and Health Professions
AS04
83%
Cancer Prevention
16%
Cancer Screening
16%
Cost Effectiveness Analysis
100%
Incremental Cost-Effectiveness Ratio
16%
Mass Immunization
16%
Papillomavirus Infection
16%
Quality Adjusted Life Year
33%
Screening
50%
Uterine Cervix Cancer
50%
Vaccination Policy
100%
Vaccine Efficacy
100%
Pharmacology, Toxicology and Pharmaceutical Science
AS04
100%
Human Papillomavirus
100%
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 6
40%
Papillomavirus Infection
20%
Uterine Cervix Cancer
60%
Vaccination Policy
100%
Vaccine
20%